Many cases of mucopurulent cervicitis (MPC) are idiopathic and cannot be attributed to the known cervical pathogens Neisseria gonorrhoeae, Chlamydia trachomatis, or herpes simplex virus. Because Mycoplasma genitalium is associated with nongonoccocal urethritis in men, its role in MPC, the corresponding syndrome in women, was investigated. Archived cervical specimens from women recruited in the Harborview Sexually Transmitted Disease Clinic in Seattle from 1984 to 1986 were tested, using polymerase chain reaction, in a study that identified other causes of and risk factors for MPC. M. genitalium was detected in 50 (7.0%) of 719 women. Young age, multiple recent partners, prior miscarriage, smoking, menstrual cycle, and douching were positively associated with M. genitalium, whereas bacterial vaginosis and cunnilingus were negatively associated. After adjustment for age, phase of menstrual cycle, and presence of known cervical pathogens, women with M. genitalium had a 3.3-fold greater risk (95% confidence interval, 1.7-6.4) of MPC, which suggests that this organism may be a cause of MPC.
ciency virus (HIV) acquisition and transmission [4] , and treatment of this syndrome can decrease cervical HIV shedding [5] . Cervicitis is caused by Neisseria gonorrhoeae, Chlamydia trachomatis, and, less often, herpes simplex virus (HSV) and Trichomonas vaginalis [3, 6, 7] . However, in many cases, no pathogen can be identified [3] , which suggests that 1 or more unidentified etiologic agents exist.
Mycoplasma genitalium, which is closely related to M. pneumoniae, was first isolated in 1981 from urethral specimens from 2 of 13 men with urethritis [8] , but the organism remains difficult to culture. The development of specific polymerase chain reaction (PCR) assays for this organism [9, 10] now allows clinical studies of its relationship to human disease. Increasing evidence implicates M. genitalium as a cause of urethritis in men; 10 of 10 studies of this relationship have demonstrated a significant association between urethritis and PCR detection of M. genitalium in urine or urethral exudate [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . These findings, in addition to PCR-based detection of M. genitalium in the female urethra, the vagina, and the cervix [9, 21] , suggest that M. genitalium may have a role in female reproductive tract disease. Our recent case-control study of Kenyan women with suspected PID demonstrated a significant association between M. genitalium and histologically diagnosed endometritis [22] . We therefore conducted the present study to characterize the association of M. genitalium with mucopurulent cervicitis (MPC) and to identify correlates of M. genitalium infection in women.
SUBJECTS, MATERIALS, AND METHODS
Study population. In a previous study that established that N. gonorrhoeae, C. trachomatis, and HSV could be causes of MPC, 779 randomly selected women aged 16-45 years who attended the Harborview Sexually Transmitted Disease (STD) Clinic between 1984 and 1986 for a new problem provided informed consent for microbiologic tests of cervical and vaginal specimens [6, 7] . For the present analysis, samples of cervical secretions from 724 women remained, and specimens from 719 of the women proved to be amplifiable by PCR for purposes of M. genitalium detection. These 719 women were similar to the 60 women for whom samples were not available or not amplifiable with respect to demographic characteristics and MPC rates. However, women for whom samples were not available were more likely to have had chlamydial infection (32.7% of women whose samples were not available vs. 11.4% of women whose samples were) or bacterial vaginosis (BV) (49.1% vs. 32.2%). This difference was probably due to depletion of specimens that tested positive for these infections through use in previous studies.
Clinical assessment. A routine medical history was taken and recorded on a standardized form by a single experienced clinician (C.E.S.), who also performed external genital and bimanual pelvic examinations, as described elsewhere [6, 7] . Samples obtained for microbiologic studies included cervical secretions collected on filter paper (Whatman #5) and stored at Ϫ20ЊC in 500 mL of PBS. "Mucopurulent cervicitis" was defined as the presence of either visible yellow mucopus or of у30 polymorphonuclear leukocytes (PMNL)/1000ϫ microscopic field on a Gram-stained smear of cervical mucus [7] . MPC was present in 215 (29.9%) of 719 women.
Laboratory methods and detection of M. genitalium. N. gonorrhoeae, C. trachomatis, HSV, M. hominis, Ureaplasma urealyticum, and Gardnerella vaginalis were detected by culture; T. vaginalis and Candida species, by culture and wet-mount microscopy; and BV, defined by Amsel's criteria [23] , as described elsewhere [7] . In the present study, cervical secretion specimens were rehydrated with 500 mL of 2SP (0.2 M sucrose, 0.02 M potassium phosphate buffer, and 0.001% phenol red [pH 7.5]), to compensate for desiccation during extended freezer storage, and processed by the Amplicor CT/NG specimen preparation kit (Roche Diagnostic Systems), according to the manufacturer's directions (the "swab procedure"). This consisted of dilution of 50 mL of the patient specimen with an equal volume of transport medium, incubation for 10 min, dilution with 100 mL of sample diluent, and use of 50 mL of this processed specimen (12.5 mL of the original pretreated specimen) in the PCR. A similar amount of original pretreated specimen (16 mL) was used in PCRs after treatment to remove inhibitors (see below). To assess the suitability of the specimens for PCR after longterm freezer storage, we tested a subset of 40 specimens (20 from N. gonorrhoeae-positive women and 20 from N. gonorrhoeae-negative women, as previously determined by culture [7] ) for N. gonorrhoeae by PCR (COBAS Amplicor; Roche Diagnostic Systems). We observed 100% concordance between these 2 tests, which indicated that bacterial DNA could be accurately detected in these specimens and that the specimens were suitable for PCR analysis.
Cervical secretions from the 724 women whose specimens were included in the present study were processed as described above and tested for M. genitalium by a PCR targeting the MgPa gene [18] that was modified by increasing the annealing temperature to 55ЊC and using a 4 mM MgCl 2 concentration. An internal control of unique DNA (to be described in a separate report [S.M.D. and P.A.T., unpublished data]) was added to the PCR mixture to detect samples inhibited for amplification. Inhibited samples ( ) were treated sequentially n p 231 as follows: (1) For all samples testing positive by the MgPa PCR assay, a second, identical MgPa PCR assay was performed on another aliquot of the sample to rule out PCR product contamination or cross-contamination. Samples that were positive for M. genitalium on both of these MgPa PCR assays ( ) were assessed n p 51 by an independent PCR assay targeting the M. genitalium 16S rDNA gene [17] . In these assays, 45 of the 51 MgPa PCR-positive samples and none of a selection of 49 MgPa PCR-negative samples had positive results with the M. genitalium 16S rDNA PCR assay. We then compared sequence similarity for the MgPa PCR products from the 6 MgPa PCR-positive, rDNA PCR-negative specimens to known M. genitalium isolates and found that 5 contained sequences nearly identical to the published MgPa sequence (GenBank accession no. M31431), which confirmed their identification as M. genitalium. The PCR product obtained after MgPa amplification of the remaining sample was unrelated to the MgPa sequence, and thus this sample was classified as M. genitalium negative. Therefore, 50 (7.0%) of the 719 women were classified as M. genitalium positive. Whenever a sample was retested, either to confirm a positive PCR result or to remove inhibitors, we used an aliquot from the original sample.
Statistical analysis. In univariate analyses, Pearson's x 2 test and Fisher's exact test were used when appropriate to assess associations between M. genitalium and categorical characteristics, and Student's t test and the Wilcoxon rank sum test were used to assess differences between groups for continuous variables. Associations, measured by the odds ratio [OR] and adjusted for relevant confounding factors, were estimated using multivariate logistic regression analyses (STATA, version 6.0). In the first model, independent risk factors (independent variables) for M. genitalium detection (dependent variable) were identified. Variables significantly associated (univariately) with M. genitalium were tested and retained if they remained significantly associated with the outcome ( ) after inclu-P р .05 sion of other potential predictors. In the second model, the association between M. genitalium (independent variable) and MPC (dependent variable) was assessed, as well as whether other known causes of cervicitis (e.g., C. trachomatis or N. gonorrhoeae infection) modified the association between M. genitalium and MPC, using a likelihood ratio test to evaluate interaction terms. Covariates included demographic characteristics and sexual behaviors, which were considered to be confounding variables and were retained in the model if the adjusted and crude ORs differed by 110%. For each cervical pathogen, the attributable proportion of MPC among women infected with that pathogen (attributable risk percentage) was estimated using the formula .
RESULTS
Demographic and behavioral characteristics of women infected with M. genitalium. The 50 women (7.0%) who were positive for M. genitalium were significantly younger, less likely to have more than a high school education or an income, and somewhat less likely to have been married at any point (P p ) than were the 669 women without M. genitalium infection .06 (table 1) . These 2 groups were similar with respect to race. Women positive for M. genitalium were less likely to use any contraception (
) and somewhat more likely to have P p .02 been pregnant during the year before the sample was obtained ( ) or to have had a spontaneous miscarriage at any P p .08 point ( ). P p .13 Women infected with M. genitalium were significantly younger at sexual debut, had engaged in sexual intercourse more recently, more often reported having у2 new sex partners in the past 30 days or having douched at least 2 times each month, and were more likely to smoke, but less often reported ever receiving cunnilingus. Associations between M. genitalium and demographic, gynecologic, and sexual behavior characteristics were similar in magnitude and statistical significance after women with N. gonorrhoeae and C. trachomatis infections were excluded, with the exception of time since last sexual intercourse, which was no longer statistically significant (data not shown).
Clinical and microbiologic findings associated with detection of M. genitalium. Women with M. genitalium infection had significantly higher vaginal and cervical PMNL counts, more often had cervical mucopus, and were somewhat more likely to have easily induced cervical bleeding than were women without such infection ( ) (table 2) . MPC was present P p .06 in 48.0% of women with and 28.6% of women without M. genitalium ( ). Women with M. genitalium complained P p .004 significantly more often of abdominal pain, vaginal discharge described as abnormal or as brown or bloody, or nausea, diarrhea, and vomiting in the previous 30 days and were more often in the proliferative phase of the menstrual cycle (days [6] [7] [8] [9] [10] [11] [12] [13] [14] . There was no association with uterine, adnexal, abdominal, or cervical motion tenderness (data not shown).
Six of the 50 M. genitalium-positive women were coinfected with N. gonorrhoeae alone, 6 with C. trachomatis alone, and 2 with both N. gonorrhoeae and C. trachomatis. Gonococcal, chlamydial, HSV, T. vaginalis, and M. hominis infections were not associated with M. genitalium, but there was a nonsignificant trend toward more frequent detection of C. albicans, G. vaginalis, and U. urealyticum among women with M. genitalium infection. M. genitalium was negatively associated with BV.
Multivariate analyses assessing risk factors, risk markers, and clinical manifestations of M. genitalium infection. Using multivariate logistic regression to simultaneously adjust for all factors in the model, we found that M. genitalium infection was associated with having у2 new partners in the past 30 days (OR, 3.3; 95% confidence interval [CI], 1.2-9.5), smoking (OR, 2.7; 95% CI, 1.3-5.7), proliferative phase of the menstrual cycle (OR, 2.6; 95% CI, 1.3-4.9), frequent douching (OR, 2.5; 95% CI, 1.1-5.6), and history of spontaneous miscarriage (OR, 2.4; 95% CI, 1.0-5.8) (
). Risk for M. genitalium infec-P p .06 tion decreased by 10% for each year of age (OR, 0.9; 95% CI, 0.81-0.95) and was reduced by 60% among women who reported a history of cunnilingus (OR, 0.4; 95% CI, 0.22-0.86) or received a diagnosis of BV (OR, 0.4; 95% CI, 0.19-0.97). Further adjustment for race, age at first intercourse, use of contraception, income, marital status, and/or education did not appreciably change the estimates.
M. genitalium infection as a risk factor for MPC. Clinical characteristics associated with MPC in univariate analyses in- 
DISCUSSION
M. genitalium was associated with a 3.3-fold greater risk of MPC, even in the absence of coinfection with N. gonorrhoeae and C. trachomatis. The magnitude of the increase in risk associated with M. genitalium was comparable with that observed for other known causes of MPC (C. trachomatis, N. gonorrhoeae, and HSV). M. genitalium infections were also associated with abdominal pain, a potential manifestation of upper reproductive tract infection; with gastrointestinal symptoms of diarrhea, nausea, and vomiting; and potentially with history of spontaneous miscarriage. Behavioral and demographic factors associated with M. genitalium infection, such as young age at sexual debut and multiple new partners within 30 days, imply that the mode of transmission is sexual. M. genitalium was also associated with factors related to alterations in the vaginal/ cervical environment, such as douching and phase of the menstrual cycle.
A study by Tully et al. [24] that showed that experimental vaginal inoculation of female primates with M. genitalium induced persistent infection and PMNL infiltration of the lower genital tract provided the first clue that M. genitalium may cause cervicitis. Two previous studies comparing M. genitalium prevalence among women with and women without cervicitis produced conflicting results [25, 26] . Uno et al. [25] found an association between M. genitalium and cervicitis in a case-control study, but the sample sizes were small, the case patients were gynecology patients, and the control subjects were pregnant women from the same clinic. Moreover, no adjustment for other cervical pathogens or potential confounding variables was performed, nor were risk factors for infection identified. Casin et al. [26] found no association between M. genitalium and cervicitis among women presenting with symptoms to an STD clinic. Unlike the present study, that study did not include asymptomatic women, MPC prevalence was extremely high (85% vs. our 30%), samples for M. genitalium detection were taken from the cervix, urethra, and/or vagina (vs. the cervix, in our study), and a different case definition for MPC was used (erythematous cervix, visible cervical mucopus, or у10 PMNL/ 1000ϫ field of a Gram-stained cervical smear, vs. our definition of visible cervical mucopus or у30 PMNL/field), which may account for the difference in findings.
In addition to morbidity associated with lower reproductive tract infection, cervical M. genitalium detection was associated with symptoms of abdominal pain, which was consistent with the results of our recent study showing an association between M. genitalium and histologically diagnosed endometritis [22] . Further studies examining possible associations of M. genitalium with PID and salpingitis are clearly warranted. Additionally, the unanticipated potential association of M. genitalium with history of spontaneous miscarriage suggests that further studies are needed that are explicitly designed to evaluate the contribution of M. genitalium to antenatal and perinatal morbidity and are adequately powered to account for the expected low prevalence of the organism in these populations [27] .
Our data support a sexual mode of transmission for M. genitalium, as do findings from serological studies that show a higher prevalence of M. genitalium antibody in groups with high, compared with low, risk of sexual exposure [28] and the concordance of M. genitalium infection status in a small group of heterosexual couples [29] . However, studies that use PCR to address the potential colonization of M. genitalium at other anatomic sites are needed to further evaluate other modes of transmission.
The association between M. genitalium and the proliferative phase of the menstrual cycle suggests that immunologic, hormonal, and/or physiologic factors related to phase of cycle may influence M. genitalium infection. Additionally, the association of M. genitalium with frequent douching and the negative associations with BV and cunnilingus suggest that the local vaginal environment might influence M. genitalium infection as well. However, these descriptive analyses lack sufficient data to explain the mechanism behind the observed associations; thus, further studies will be necessary to clarify these relationships.
The strong associations between M. genitalium and urethritis, cervicitis, and endometritis suggest that M. genitalium infections may require treatment. However, the assessment of antimicrobial susceptibility is challenging, because the organism is difficult to grow and a limited number of strains have been isolated. Despite reports of in vitro susceptibility of M. genitalium to several commonly used antimicrobial agents [30, 31] , intermediate resistance in vitro to tetracycline [31] and persistent detection of M. genitalium in vivo after tetracycline [13, 16, 32] and azithromycin [16] therapy suggests that some strains may be resistant to these compounds. Definition of optimal treatment regimens for M. genitalium will require susceptibility tests that use a diverse set of contemporary strains and larger treatment trials incorporating evaluation of sexual partners to differentiate between treatment failure and reinfection.
Cross-sectional studies in STD clinics that incorporate systematic clinical and microbiologic evaluations have proved to be useful in establishing disease associations, and the relationships we observed between clinical manifestations and M. genitalium infection were strong. However, the cross-sectional nature of this study does not permit conclusions to be made about causality and/or temporal sequence between M. genitalium infection and disease manifestations. Additionally, risk behaviors associated with M. genitalium may be better studied in populations with greater heterogeneity of risk behaviors, and the risk factors identified here should be confirmed in other groups. Furthermore, these associations should be confirmed in other settings and in present-day populations to accurately reflect current population dynamics.
Additional limitations of our study include the following: Although the selective depletion of samples from women with chlamydial infection or BV may have biased calculations of the associations of M. genitalium with those infections, our observed association between M. genitalium and MPC should not have been affected. In addition, it is unclear whether the large number of initially inhibited samples (231 [31.9%] of 724 samples), which tended to be from women with intermenstrual bleeding, elevated levels of PMNL in cervical samples, yellow cervical or vaginal discharge, BV, or N. gonorrhoeae, T. vaginalis, or M. hominis infection more often than from women with M. genitalium infection (data not shown), had an effect on the observed association between M. genitalium detection and MPC. The higher proportion of M. genitalium-positive results among the uninhibited specimens may be due to the presence of samples that were strongly positive for M. genitalium and could amplify with the M. genitalium primers even in the presence of low levels of inhibition. Alternatively, the 1:5 dilution required to remove the inhibition also may have diluted the quantity of M. genitalium DNA to levels below the point of reliable detection, resulting in false-negative results. If falsenegative results were more likely in samples from women without MPC, the association we observed between M. genitalium and MPC would be an overestimation of the true association. However, inhibited samples in our study were more often from women with MPC; furthermore, these samples were less likely to be positive for M. genitalium. Thus, it is more likely that our estimate of the association between M. genitalium and MPC is a conservative one.
In summary, M. genitalium was strongly and independently associated with MPC in this group of women, which suggests that M. genitalium infection may cause cervical inflammation. Once these results are confirmed and studies designed to assess causality have been done, M. genitalium should be considered among the potential etiologic agents for MPC, particularly when it is detected in the absence of N. gonorrhoeae and C. trachomatis infection. the "AR, %" (i.e., attributable risk percent) for M. genitalium should be 70 (rather than 7). The authors regret this error.
